Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

CHRS stock price forecast

How will CHRS stock perform in 2026 and 2030?

This page primarily displays the projected price range for CHRS stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of CHRS, the development trends of Coherus Oncology, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for CHRS. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Coherus Oncology, Inc.'s financial performance and industry trends to provide short-term price predictions for CHRS stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year CHRS stock price forecast

Price target:
3.21 USD
+99.38%
Based on 1-year price forecasts from 40 analysts, the highest estimate is 4.33 USD, while the lowest estimate is 1.74 USD.

Analyst rating for CHRS

Based on ratings from 35 analysts over the past three months, the overall consensus is Buy.

Strong buy
15
Buy
8
Hold
0
Sell
8
Strong sell
4

Tez-tez beriladigan savollar

How has CHRS's EPS performed recently?

CHRS's EPS is projected to reach -- USD next quarter. Explore more Coherus Oncology, Inc. financial data and stay up to date on the company's latest developments on the CHRS stock details page.

What is the revenue forecast for CHRS next quarter?

Coherus Oncology, Inc.'s revenue is projected to reach 13.91M USD USD in the next quarter. You can view Coherus Oncology, Inc.'s revenue and earnings on the CHRS stock details page.

What is the price target for CHRS?

Based on analyst estimates, the most likely target price for CHRS over the next 12 months is 3.21 USD, with a projected high of 4.33 USD and a projected low of 1.74 USD. To track whether this target is reached within the next year, you can view the CHRS stock price chart on the CHRS stock details page to check the current CHRS stock price, or follow the latest developments related to CHRS on the CHRS Stock News page.

What is the analyst rating for CHRS?

We collected ratings from 35 analysts who have evaluated CHRS stock over the past three months. Most analysts maintain a Buy outlook, and after aggregating all opinions, the overall consensus rating is Buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of CHRS stock in 2030?

Based on price forecasts and analyses of Coherus Oncology, Inc. from Wall Street analysts and major investment banks, CHRS is projected to trade between 3.22 USD and 16.10 USD in 2030.

CHRS stock chart

CHRS stock details

CHRS aksiya narxining o'zgarishi

Oxirgi savdo kunida, CHRS aksiya 1.61 USD narxda yopildi, kun uchun narx o'zgarishi -19.90%.

Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
NASDAQ/
CHRS stock price forecast